Projects per year
Personal profile
Education
- 1997-2004 M.D., Faculty of Medicine, National Yang-Ming University
Experience
- 2022.08- Director, Division of Hematology, School of Medicine, College of Medicine, Taipei Medical University
- 2020.09- Director, Division of Hematology, Department of Medial Internal Medicine, Taipei Medical University Shuang Ho Hospital
- 2019.08- Assistant Professor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2013.02-2019.07 Instructor, Department of Internal Medicine, School of Medicine, Taipei Medical University
- 2012- Chief of hemato-oncology ward of Shuang-Ho Hospital
- 2012- Chief of Safety of chemotherapeutic agent sub-team of Cancer committee of Shuang Ho Hospital
- 2011- Lecturer, school of medicine, Taipei Medical University
- 2011.09-2012.07 Lecturer, National Yang-Ming University, school of medicine
- 2010.11- Visiting Staff of Shuan-ho Hospital, Department of internal medicine, Division of Hematology and Oncology
- 2010.10-2010.11 Visiting Staff of Taipei Veterans General Hospital, Department of internal medicine, Division of Hematology and Oncology
- 2007-2010 Chief resident of Taipei Veterans General Hospital, Department of internal medicine, Division of Hematology and Oncology
- 2004-2007 Resident doctor of Taipei Veterans General Hospital
- 2002 Official Committee of August Meeting 2002 of International Federations of Medical Students Association
- 2002 Visiting student to Tromsoe University, Tromsoe, Norway
Awards
- 2009 Hsieh YY, Liu CY, Lin HN, Liu JH, Gau JP, Hsiao LT, Yu YB, Chiou TJ, Chen PM, Tzeng CH. Hematopoietic Stem Cell Transplantation (HSCT) for Cytogenetically Normal AML Patients at First Complete Remission-experience from Taipei Veterans General Hospital. The 14th APBMT, outstanding poster award
Research Interests
- Clinical trial
- clinical data mining of Gastrointestinal tract cancer
- drug resistance of chemotherapeutic drug in gastrointestinal tract cancer
Fingerprint
Dive into the research topics where Yao-Yu Hsieh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting the Oncogenic Mir31hg/Mir-31 Regulatory Network for Improving Pancreatic Cancer Treatment( II )
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Significance of Dual Targeting on Btk/Bcl2l11 Axis in the Context of Cisplatin-Tolerant Persister Esophageal Cancer
Hsieh, Y.-Y. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Targeting the Oncogenic Mir31hg/Mir-31 Regulatory Network for Improving Pancreatic Cancer Treatment( I )
Hsieh, Y.-Y. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
布鲁頓酪氨酸激酶(Bruton's tyrosine kinase , BTK)對頑固型耐藥食道癌細胞鐵死亡敏感性之機制研究
Hsieh, Y.-Y. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Repurposing of a Positive Allosteric Modulator of M5 Muscarinic Acetylcholine Receptor as a Microtubule-Targeting Agent and Its Application for Treating Pancreatic Ductal Adenocarcinoma
Hsieh, Y.-Y. (PI)
1/1/19 → 6/1/20
Project: A - Government Institution › b - National Science and Technology Council
-
Correction to: Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker (Diagnostics, (2023), 13, 13, (2296), 10.3390/diagnostics13132296)
Ong, K. H., Hsieh, Y. Y., Sun, D. P., Huang, S. K. H., Tian, Y. F., Chou, C. L., Shiue, Y. L., Joseph, K. & Chang, I. W., Feb 2025, In: Diagnostics. 15, 3, 391.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinoma
Luo, P. J., Chuang, K. I., Ni, C. F., Yeh, H. Y., Wu, M. S., Hsieh, Y. Y., Kao, W. Y. & Wu, C. H., 2025, (Accepted/In press) In: Journal of the Formosan Medical Association.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma
Wang, S. H., Hsieh, Y. Y., Ong, K. H., Lai, H. Y., Tsai, H. H., Sun, D. P., Huang, S. K. H., Tian, Y. F., Wu, H. C., Chan, T. C., Joseph, K. & Chang, I. W., Jan 2025, In: Asian Journal of Surgery. 48, 1, p. 250-260 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance
Hsieh, Y. Y., Du, J. L. & Yang, P. M., Feb 2024, In: Molecular Oncology. 18, 2, p. 386-414 29 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Ten-year epidemiology and risk factors of cytomegalovirus infection in hematopoietic stem cell transplantation patients in Taiwan
Huang, Y. C., Hsiao, F. Y., Guan, S. T., Yao, M., Liu, C. J., Chen, T. T., Lin, T. L., Liu, Y. C., Chen, T. Y., Hong, Y. C., Ma, M. C., Tan, T. D., Wang, C. C., Wu, Y. Y., Liao, P. W., Wu, Y. F., Chen, Y. Y., Yu, Y. B., Hsieh, Y. Y. & Lee, M. Y. & 3 others, , 2024, (Accepted/In press) In: Journal of Microbiology, Immunology and Infection. 57, 3, p. 365-374 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)
Datasets
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Contributor), Chou, C.-J. (Contributor) & Yang, P.-M. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.7346312.v1, https://rs.figshare.com/articles/journal_contribution/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7346312/1
Dataset
-
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Creator), Chou, C.-J. (Contributor) & Yang, P.-M. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v1, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/1
Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Contributor), Chou, C.-J. (Contributor) & Yang, P.-M. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.7375601.v1, https://rs.figshare.com/articles/Supplementary_data_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining/7375601/1
Dataset
-
Supplementary data from Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining.
Liu, T.-P. (Contributor), Yang, P.-M. (Creator), Hsieh, Y.-Y. (Creator) & Chou, C.-J. (Contributor), The Royal Society, 2018
DOI: 10.6084/m9.figshare.7346312.v2, https://doi.org/10.6084%2Fm9.figshare.7346312.v2
Dataset
-
Supplementary material from "Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining"
Liu, T.-P. (Contributor), Hsieh, Y.-Y. (Creator), Chou, C.-J. (Contributor) & Yang, P.-M. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4302764.v2, https://figshare.com/collections/Supplementary_material_from_Systematic_polypharmacology_and_drug_repurposing_via_an_integrated_L1000-based_Connectivity_Map_database_mining_/4302764/2
Dataset